Image annotation for NCI clinical research databases
Ended Awarded Last action
- Contract number
- 75N91020F00031
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,673,614
Award facts
- Contract value 100% obligated
- $3,673,614.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,673,614 |
About this award
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Leidos Biomedical Research Inc. for "IMAGE ANNOTATION FOR NCI CLINICAL RESEARCH DATABASES". The contract has an ultimate completion date of September 21, 2025 and a ceiling value of $3,673,614.00. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and serves as a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a range of biomedical research and facilities support services. This contract does not have a set-aside designation. The contract is associated with a larger single-award Indefinite Delivery Contract from the NCI with a potential value of $6.6 billion over a 5-year base period, under which Leidos Biomedical Research Inc. delivers a wide range of services through individual task orders.
Quick answers
Who was awarded contract 75N91020F00031?
75N91020F00031 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2020.
How much is contract 75N91020F00031 worth?
The government has obligated $3,673,614 on 75N91020F00031.
Is contract 75N91020F00031 an order under another contract?
Yes. 75N91020F00031 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00031 competed?
The extent of competition for 75N91020F00031 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award